Reneo Pharmaceuticals Analysis
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Reneo Pharmaceuticals is overvalued with Real Value of 14.48 and Hype Value of 18.65. The main objective of Reneo Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Reneo Pharmaceuticals is worth, separate from its market price. There are two main types of Reneo Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Reneo Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Reneo Pharmaceuticals is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Reneo Stock trading window is adjusted to America/New York timezone.
Reneo |
Reneo Stock Analysis Notes
About 88.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reneo Pharmaceuticals recorded a loss per share of 16.8. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 7th of October 2024. Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. To find out more about Reneo Pharmaceuticals contact Gregory Flesher at 858 283 0280 or learn more at https://reneopharma.com.Reneo Pharmaceuticals Investment Alerts
| Reneo Pharmaceuticals is now traded under the symbol OKUR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Reneo Pharmaceuticals is not yet fully synchronised with the market data | |
| Reneo Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Reneo is showing solid risk-adjusted performance over 90 days | |
| Reneo Pharmaceuticalshas 3,398,311 shares shorted by Reneo Pharmaceuticals investors is about 100% of outstending shares | |
| Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reneo Pharmaceuticals currently holds about 126.85 M in cash with (63.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.18. | |
| Over 88.0% of the company shares are owned by institutional investors |
Reneo Pharmaceuticals Upcoming and Recent Events
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Reneo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.08 M.Reneo Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Reneo Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Reneo Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Reneo Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Reneo Pharmaceuticals Outstanding Bonds
Reneo Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Reneo Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Reneo bonds can be classified according to their maturity, which is the date when Reneo Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NECELE 217 25 NOV 26 Corp BondUS75972BAB71 | View | |
| RENAISSANCERE FIN INC Corp BondUS75973QAA58 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Reneo Pharmaceuticals Predictive Daily Indicators
Reneo Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Reneo Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Reneo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Reneo Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Reneo shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Reneo Pharmaceuticals. By using and applying Reneo Stock analysis, traders can create a robust methodology for identifying Reneo entry and exit points for their positions.
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company was incorporated in 2014 and is headquartered in Irvine, California. Reneo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Reneo Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |